BioCentury | Dec 2, 2019
Company News

Innovent’s Tyvyt edges out PD-1s on China’s 2020 reimbursement list

...HCV drugs Epclusa sofosbuvir/velpatasvir and Harvoni sofosbuvir/ledipasvir from Gilead Sciences Inc. (NASDAQ:GILD) and Merck’s Zepatier elbasvir/grazoprevir...
BioCentury | Aug 28, 2019
Politics & Policy

Aug. 28 P&P Quick Takes: Liver failure warning for HCV drugs; plus FDA guidances and more

...in patients with liver impairment taking HCV drugs Mavyret glecaprevir/pibrentasvir from AbbVie Inc. (NYSE:ABBV), Zepatier grazoprevir/elbasvir...
BioCentury | Mar 5, 2019
Company News

Lilly offers cheaper insulin, pressuring competitors

...disease and hyperlipidemia drug Repatha evolocumab; Merck & Co. Inc. (NYSE:MRK) with HCV drug Zepatier grazoprevir/elbasvir...
BioCentury | Mar 1, 2019
Company News

Ex-Merck China R&D head joins Ascletis as CMO

...more than 10 products for MSD China, including anti-PD-1 mAb Keytruda pembrolizumab, HCV drug Zepatier grazoprevir/elbasvir...
BioCentury | Sep 28, 2018
Company News

Gilead targets Medicaid with launch of HCV generics

...In July, Merck & Co. Inc. (NYSE:MRK) cut the WAC of its HCV drug Zepatier grazoprevir/elbasvir...
BioCentury | Sep 24, 2018
Company News

Gilead targets Medicaid with launch of HCV generics

...In July, Merck & Co. Inc. (NYSE:MRK) cut the WAC of its HCV drug Zepatier grazoprevir/elbasvir...
BioCentury | Aug 24, 2018
Politics, Policy & Law

The Louisiana purchase

...but pricing pressure remains high. In July, Merck cut the list price of its Zepatier grazoprevir/elbasvir...
BioCentury | Aug 10, 2018
Company News

Zepatier lands co-exclusive status on Express Scripts 2019 formulary

...rebate as in years past, but also by lower list prices, garnering HCV drug Zepatier grazoprevir/elbasvir...
BioCentury | Aug 7, 2018
Company News

Zepatier lands co-exclusive status on Express Scripts 2019 formulary

...rebate as in years past, but also by lower list prices, garnering HCV drug Zepatier grazoprevir/elbasvir...
BioCentury | Jul 21, 2018
Politics, Policy & Law

Getting serious

...price increases below inflation.” Merck recorded no sales in 1Q18 of the HCV drug Zepatier grazoprevir/elbasvir...
Items per page:
1 - 10 of 92